From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. HIV/AIDS Clinical Care>
  4. Editor's Picks

HIV/AIDS Editor's Picks

SUMMARY AND COMMENT

Neurologic Effects of Early HIV Infection

Significant structural brain changes are found within the first 6 months of HIV infection.

SUMMARY AND COMMENT

Sexually Transmitted Infections Acquired During Travel

A GeoSentinel analysis identified several risk factors for travel-associated STIs, including male sex and lack of a pretravel health consultation.

SUMMARY AND COMMENT

Renal Safety of Treatment for Chronic HBV Infection

Nephrotoxicity was similar with tenofovir or entecavir.

SUMMARY AND COMMENT

High and Varied Levels of Multidrug-Resistant Tuberculosis

Among isolates from patients with MDR-TB, 44% showed resistance to at least one second-line drug, and 7% were extensively resistant.

SUMMARY AND COMMENT

Reducing the Rate of Active TB by Targeted Testing and TreatmentFree

Such a program, initiated by the Tennessee Department of Health, prevented an estimated 184 cases of active tuberculosis during its first 5 years.

SUMMARY AND COMMENT

HBV or HCV Infection: Which Is Worse?

In a cohort of men who have sex with men, hepatitis B virus infection conferred a higher risk for liver-related mortality than did hepatitis C virus infection.

SUMMARY AND COMMENT

Trends in HIV Risk Behaviors in Teens from 1991 to 2011

Improvements in the first decade are now dangerously stalled.

SUMMARY AND COMMENT

Antiviral Therapy Safely Stopped in HBeAg-Negative Patients with Hepatitis B Infection

Discontinuing adefovir did not lead to any adverse events during 5.5 years of follow-up. CME

SUMMARY AND COMMENT

False-Positive Interferon Assays for Latent Tuberculosis

One hospital's experience suggests routinely repeating tests in converters.

SUMMARY AND COMMENT

Metronidazole for TB?

A 2-month metronidazole regimen was as effective as a 6-month isoniazid regimen in a macaque model of latent TB.

Read more HIV/AIDS Editor's Picks articles >>

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

Browse arrow

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Copyright © 2013. Massachusetts Medical Society. All rights reserved.